Primary Immunosuppresive Treatment of Ocular Myasthenia Gravis with Cyclosporine A

Update item information
Identifier 19980325_nanos_sciplatform3_01
Title Primary Immunosuppresive Treatment of Ocular Myasthenia Gravis with Cyclosporine A
Creator Preston C Calvert, MD
Subject Immunosuppressive Treatment; Ocular Myasthenia Gravis; Cyclosporine A
Description Immunosuppressive therapy for ocular myasthenia gravis (MG) has usually consisted of systemic corticosteroids or azathioprine. Although each drug can induce a remission, each has drawbacks. Cyclosporine A (CsA) has been demonstrated in a controlled trial to be effective and safe in the suppression of MG. I report here my experience with 8 patients with ocular MG treated with CsA as the primary immunosuppressive modality.
Relation is Part of NANOS 1998: Platform Presentations (Session III)
Contributor Primary Calvert, Preston C
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 1998-03-25
Type Text
Format application/pdf
Format Creation application/pdf
Source 1998 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 1998. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s6cg2wvg
Setname ehsl_novel_nam
Date Created 2014-10-28
Date Modified 2021-05-06
ID 184376
Reference URL https://collections.lib.utah.edu/ark:/87278/s6cg2wvg